InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the complete record of transactions filed by GILL DAVID N, Director. Officer active across 3 companies, notably Strongbridge Biopharma plc. In total, 11 filings have been recorded. Total volume traded: €67k. The latest transaction was filed on 13 May 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations11 total
€67,0405,313 shares@ €12.6180.016% mcap100.0% of flow
Common Stock
SEC:0001570562-22-000104:0·
015,568 shares0
Common Stock
SEC:0001570562-22-000049·
015,568 shares0
Common Stock
SEC:0001570562-22-000049:0·
78,058 shares
Ordinary Shares
SEC:0001179110-21-009277·
78,058 shares
Ordinary Shares
SEC:0001179110-21-009277:0·
€31,61417,763 shares@ €1.7798100.0% of flow
Ordinary Shares
SEC:0001179110-21-009218·
€31,61417,763 shares@ €1.779829.9% of flow
Ordinary Shares
SEC:0001179110-21-009218:0·
040,000 shares0
Ordinary Shares
SEC:0001179110-21-005555·
040,000 shares0
Ordinary Shares
SEC:0001179110-21-005555:0·
€37,11619,075 shares@ €1.9458100.0% of flow
Ordinary Shares
SEC:0001179110-21-005441·
€37,11619,075 shares@ €1.945835.1% of flow
Ordinary Shares
SEC:0001179110-21-005441:0·
11 of 11 declarations
About GILL DAVID N
David N. Gill serves as a Board Member at Strongbridge Biopharma plc and Evolus, Inc. In this role, he oversees the operations of these companies and participates in strategic decision-making. His expertise in the biopharmaceutical sector allows him to provide significant contributions to the board.
